Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity

mBio

Volumn 3, Issue 2, 2012, Pages

  Rand, Jacob H ^a   Wu, Xiao Xuan ^a   Lin, Elaine Y ^a   Griffel, Alexander ^a   Gialanella, Philip ^a   McKitrick, John C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; PHOSPHATIDYLSERINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE RELEASE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; LIGAND BINDING; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; SHEWANELLA PUTREFACIENS; TOXIN ANALYSIS;

LIMULUS; MUS; NEGIBACTERIA;

EID: 84860521169     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00292-11     Document Type: Article

References (38)

1. Reviakine I, Bergsma-Schutter W, Brisson A. 1998. Growth of protein 2-D crystals on supported planar lipid bilayers imaged in situ by AFM. J. Struct. Biol. 121:356-361.
2. Bratton DL, et al. 1997. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J. Biol. Chem. 272: 26159-26165.
3. Mirnikjoo B, Balasubramanian K, Schroit AJ. 2009. Suicidal membrane repair regulates phosphatidylserine externalization during apoptosis. J. Biol. Chem. 284:22512-22516.
4. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184:39-51.
5. Gerke V, Moss SE. 2002. Annexins: from structure to function. Physiol. Rev. 82:331-371.
6. Andree HA, et al. 1990. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J. Biol. Chem. 265:4923-4928.
7. Tait JF, Gibson D, Fujikawa K. 1989. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J. Biol. Chem. 264:7944-7949.
8. Cederholm A, Frostegård J. 2007. Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann. N. Y. Acad. Sci. 1108:96-103.
9. Cederholm A, et al. 2005. Decreased binding of annexin V to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arterioscler. Thromb. Vasc. Biol. 25: 198-203.
10. Hunt BJ, et al. 2011. Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome. Am. J. Obstet. Gynecol. 205:485.e17-485.e23.
11. Rand JH, et al. 1997. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N. Engl. J. Med. 337: 154-160.
12. Wu XX, Guller S, Rand JH. 2011. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression. Am. J. Obstet. Gynecol. 205:576.e7-576.e14.
13. Ravassa S, et al. 2005. Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoir. J. Biol. Chem. 280:6028-6035.
14. Kenis H, et al. 2004. Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J. Biol. Chem. 279: 52623-52629.
15. Kenis H, et al. 2006. Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp. Cell Res. 312: 719-726.
16. Katayanagi K, et al. 1999. Generation of monoclonal antibodies to murine bile duct epithelial cells: identification of annexin V as a new marker of small intrahepatic bile ducts. Hepatology 29:1019-1025.
17. Rieanrakwong D, Yonezawa T, Kurusu S, Kawaminami M. 2010. Immunohistochemical localization of annexin A5 in the mammary gland of rats: up-regulation of expression by pup removal. J. Vet. Med. Sci. 72: 19-22.
18. Peri F, Piazza M. 2012. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. Biotechnol. Adv. 30: 251-260.
19. Takeda K. 2010. The lipid A receptor. Adv. Exp. Med. Biol. 667:53-58.
20. Harel M, Aron-Maor A, Sherer Y, Blank M, Shoenfeld Y. 2005. The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. Immunobiology 210:743-747.
21. Krauel K, et al. 2011. Platelet factor 4 binds to bacteria, inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. Blood 117:1370-1378.
22. Rietschel ET, et al. 1987. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog. Clin. Biol. Res. 231:25-53.
23. Vishnyakova TG, et al. 2003. Binding and internalization of lipopolysaccharide by Cla-1, a human ortholog of rodent scavenger receptor B1. J. Biol. Chem. 278: 22771-22780.
24. Cuypers PA, et al. 1983. The adsorption of prothrombin to phosphatidylserine multilayers quantitated by ellipsometry. J. Biol. Chem. 258: 2426-2431.
25. Rand JH, et al. 1998. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Blood 92:1652-1660
26. Levin J, Watson SW, Novitsky TJ. 1987. Detection of bacterial endotoxins with the Limulus amebocyte lysate test. Proceedings of an international congress. Woods Hole, Massachusetts, September 8-11, 1985. Prog. Clin. Biol. Res. 231:1-587.
27. Hawiger J. 2001. Innate immunity and inflammation: a transcriptional paradigm. Immunol. Res. 23:99-109.
28. Valledor AF, Comalada M, Santamaría-Babi LF, Lloberas J, Celada A.2010. Macrophage proinflammatory activation and deactivation: a question of balance. Adv. Immunol. 108:1-20.
29. Suffredini AF, Munford RS. 2011. Novel therapies for septic shock over the past 4 decades. JAMA 306:194-199.
30. Krasity BC, Troll JV, Weiss JP, McFall-Ngai MJ. 2011. LBP/BPI proteins and their relatives: conservation over evolution and roles in mutualism. Biochem. Soc. Trans. 39:1039-1044.
31. Andrä J, Gutsmann T, Müller M, Schromm AB. 2010. Interactions between lipid A and serum proteins. Adv. Exp. Med. Biol. 667:39-51.
32. Eberhard DA, Vandenberg SR. 1998. Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins. Biochem. J. 330:67-72.
33. Flaherty MJ, West S, Heimark RL, Fujikawa K, Tait JF. 1990. Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system. J. Lab. Clin. Med. 115:174-181.
34. Krikun G, et al. 1994. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 15:601-612.
35. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165:618622.
36. Rand JH, et al. 2006. Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am. J. Obstet. Gynecol. 194:182-188.
37. Rand JH, et al. 2003. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am. J. Pathol. 163:1193-1200.
38. Wright SF, Morton JB. 1989. Detection of vesicular-arbuscular mycorrhizal fungus colonization of roots by using a dot-immunoblot assay. Appl. Environ. Microbiol. 55:761-763.